Abstract
The use of human postmortem brain tissue in neurochemical and neuropharmacological research has received increasing attention over recent years. In fact, there is one work that, more than any other, can be identified as being responsible for the interest in this approach. It was Birkmayer and Hornykiewicz who, having observed a deficit in the content of the neurotransmitter dopamine in brain tissue taken postmortem from patients with Parkinson’s disease, set about to counteract this deficit in living patients by treatment with L-dopa. The identification of an abnormally low transmitter concentration and its supplementation by the administration of the appropriate biochemical precursor has revolutionized the treatment of this disease (Ehringer and Hornykiewicz, 1960; Birkmayer and Hornykiewicz, 1961). It has also served to motivate neurochemists to study other neurological and psychiatric diseases using postmortem brain tissue. Such a success story has yet to be repeated. Nevertheless, neurochemical and other molecular approaches to studying the diseased brain have generated a large amount of information that has increased enormously our understanding of the molecular neuropathology and neural dysfunction in these disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anderson R E. and Hill R. B (1989) The current status of the autopsy in academic medical centers m the United States Am J Clin Psychol 92, 31–37
Andrion A and Pira E. (1994) What’s new in managing health hazards in athology departments Pathol Res Practice 190, 1214–1223
Ang L C and Shul D D (1995) Peptidergic neurons of subcortical white matter n aging and Alzheimer’s brain Brain Res 674, 329–335
Aquilonius S M., Eckernas S A., and Gillberg P G (1983) Large section ryomicrotomy in human neuroanatomy and neurochemistry, in Brain icrodissection Techniques (Cuello A C, ed), IBRO/Wiley, London, pp 155–170
Aquilonius S. M. (1986) Large section cryomicrotomy A basic method for icrodissectioning and in vitro autoradiography of human nervous tissue Upsala J Med Sci 91, 245–250
Barton A J L, Pearson RCA, Najlerahim A and Harrison P. J (1993) Pre-and post-mortem influences on brain RNA J Neurochem 61, 1–11
Battiflora H and Kopmski M (1986) The influence of protease digestion and uration of fixation of fixation on the immunostaining of keratins J Histochem Cytochem 34, 1095
Benes F M, Paskevich V. A, Davidson J and Domesick V B. (1985) Synaptic earrangements in medial prefrontal cortex of halopendol-treated rats Brain Res 348, 15–20
Berger J R. and David N. J. (1993) Creutzfelt-Jakob disease in a physician A eview of the disorder in health care workers Neurology 43, 205,206
Birkmayer W and Hornykiewicz O (1961) Der L-Dioxyphenylanin (L-DOPA) ffekt bei der Parkinson-Akinesie. Wten Klin Wochenschr 73, 787
Birkmayer W and Riederer P (1983) Parkinson’s Disease. Springer, Vienna
Bowen D. M., Smith C B., White P., Goodhards M. J, Spillane J. A, Flack R. H and Davidson A N (1977) Chemical pathology of organic dementia Validity of biochemical measurements on human post-mortem brain specimens brain 100, 397–426
Bowen D M, Sims N R, Lee K. A P, and Marek K L (1982) Acetylcholine ynthesis and glucose oxidation are preserved in human brain obtained hortly after death Neurosci Lett. 31, 195–199
Bowen D M, Najlerahim A, Procter A. W, Francis P T and Murphy E (1989) ircumscribed changes in the cerebral cortex in neuropsychiatric disorders of later life Proc Natl Acad Set USA 86, 9504–9508
Bucht G, Adolfsson R., Gottfries C. G., Ross B E, and Winblad B (1981) Distribution of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in human rain in relation to age, drug influence, agonal status and circadian variation. J Neural Transm 51, 185–203
Burke W J., O’Malley K L, Chung H. D, Harmon S K., Miller J P and Berg L 1991) Effect of pre-and post-mortem variables on specific mRNA levels in human brain Mol Brain Res 11, 37–41
Butterworth J. (1986) Changes in nine enzyme markers for neurons, gha and ndothelial cells in agonal state and Huntington’s disease caudate nucleus. J Neurochem 47, 583–587
Carlsson A, Svennerholm L, and Winblad B. (1980) Seasonal and circadian onoamine variations in human brain examined postmortem. Acta Psychiatr cand. 61Suppl 280, 75–85.
Clow A, Theodorou A, Jenner P. and Marsden C. D. (1980) Changes in rat striatal dopamine turnover and receptor activity during one year’s neuroleptic dministration. Eur J Pharmacol 63, 135–144
Cortes R, Gueye B, Pazos A., Probst A. and Palacios J M (1989) Dopamine eceptors in human brain autoradiographic distribution of Dl sites. Neuroscience 28, 263–273
Cruz-Sanchez F F and Tolosa E. (1993) How to run a brain bank preface J Neural Transm. Suppl39, 1.
Currasco L H. and Mukherji C S (1986) Atrophy of corpus striatum in normal ale at risk of Huntington’s chorea. Lancet 1, 1388,1389.
Cutts A J. and Reynolds G P (1993) D-Aspartate binding to the glutamate ptake site in human brain tissue-effects of leucotomy. J Neural Transm 94, 47–152.
Damask S P., Bovenkirk K A, De la Pena G, Hoversten K M, Peters D B., alentine A M and Meador Woodruff J H (1996) Differential effects of lozapine and halopendol on dopamine receptor mRNA expression in rat triatum and cortex Mol Brain Res. 41, 241–249
Dapson R. W (1991) Fixation for the 1990’s. A review of needs and accomplishments Biotech Histochem 68, 75–82
Dean B., Crook J. M., Opeskin K, Hill C, Keks N. and Copolov D L. (1996) The ensity of muscarinic Ml receptors is decreased in the caudate-putamen of ubjects with schizophrenia. Mol Psych 1, 54–58.
Dodd P R, Hambley J W., Cowburn R. F and Hardy J A. (1988) A comparison of methodologies for the study of functional transmitter neurochemistry in human brain J Neurochem 50, 1333–1345.
Ehringer H. and Hornykiewicz O. (1960) Verteilung von Noradrenalin und opamin im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des xtrapyramidalen Systems Wien Klin. Wochenschr 72, 12–16.
Elwan M A. and Soliman M. R I. (1995) Alteration of Dl and D2 dopaminergic eceptor kinetics in specific rat brain regions following repeated administration of opiates Pharmacology 51, 73–83.
Emson P. C, Rossor M, Hunt S. P., Clement-Jones V, Fahrenkrug J, and Rehfeld J. (1981) Neuropeptides in human brain, in Transmitter Biochemistry of Human rain Tissue (Riederer P. and Usdin E., eds), Macmillan, London, pp. 221–234
Gilbert J M., Brown B. A., Strocchi P, Bird E. D., and Marotta C A. (1981) The reparation of biologically active messenger RNA from human postmortem rain tissue J Neurochem 36, 976–984.
Gorman D G, Benson D F, Vogel D G and Vinters H V (1992) Creutzfelt-Jakob disease in a pathologist Neurology 42, 463.
Gottfries C G, Adolfsson R., and Winblad B (1981) Analytical problems in ostmortem brain studies, in Transmitter Biochemistry of Human Brain Tissue (eiRiederer P and Usdin E, eds), Macmillan, London, pp 47–54
Haan E A and Bowen D M (1981) Protection of neocortical tissue prisms from reeze-thaw injury by dimethyl sulphoxide J Neurochem 37, 243–246
Hardy J A, Dodd P R, Oakley A E, Kidd A M, Perry R H, and Edwardson A (1982) Use of postmortem human synaptosomes for studies of metabolism and transmitter amino acid release Neurosci Lett 33, 317–322
Hardy J A and Dodd P R. (1983) Metabolic and functional studies on postmortem human brain Neurochem Int 5, 257–266
Hardy J A., Dodd P R, Oakley A E, Perry R H, Edwardson J A, and Kidd M (1983) Metabohcally active synaptosomes can be prepared from frozen rat and human brain J Neurochem 40, 608–614
Harrison P. J and Pearson R C A (1990) In situ hybridisation histochemistry nd the study of gene expression in the human brain Prog Neurobiol 34, 71–312
Harrison P J, Proctor A W, Barton A J L, Lowe S L, Najlerahim A, Bertolucci H F, Bowen D M. and Pearson R C A (1991) Terminal coma affects uscarinic receptor mRNA detection in post-mortem human temporal cortex Mol Brain Res 9, 161–164
Harrison P. J, Barton A J L., Proctor A W, Bowen D M and Pearson R C A 1994) The effects of Alzheimer’s disease, other dementias and pre-mortem ourse upon amyloid β precurser protein messenger RNAs in frontal cortex J Neurochem 62, 635–644
Harrison P J, Heath P R, Eastwood S L, Burnet P W J, McDonald B and earson R C A (1995) The importance of pre-mortem brain acidosis and ost-mortem interval for gene expression studies Selective vulnerability mongst mRNAs, and a comparison with encoded epitopes and receptor inding studies Neurosci Lett 200, 151–154
Heath P R, Denney H A, Sanders M W, Vardy E and Pearson R C A (1996)The se of human post-mortem brain tissue for in situ hybridisation Practical considerations, in IBRO Handbook Series Methods in the Neurosciences vol 17, In Situ ybridisation Techniques for the Brain (Henderson, Z, ed), Wiley, pp 119–131
Hruska R E and Silbergeld E K (1980) Estrogen treatment enhances dopamine receptor sensitivity in the rat striatum Eur J Pharmacol 61, 353–400
Hunt S P, Rossor M. N, Emson P E., and Clement-Jones V (1982) Substance P nd enkephalins in the spinal cord following limb amputation Lancet, 1023
Karson C. N., Berman K F., Klemman J., and Karoum F (1984) Seasonal variaion in human central dopamine activity Psychiatr Res 11, 111–117
Kitamoto T, Ogomon K, Tateishi J and Prusiner S B (1987) Methods in laboratory investigation Formic acid pretreatment enhances immunostaining of erebral and systemic amyloids Lab Invest 57, 230–236
Lucena J, and Cruz-Sanchez F F (1993) The interest of the neurological tissue reservation for the investigation of sudden infant death syndrome J Neural Transm Suppl39, 193–205
Mackay A V P, Bird E D, Spokes E, Rossor, M, Iversen L L, Creese I, and Snyder S H (1980) Dopamine receptors and schizophrenia drug effect or llness? Lancet ii, 223–225
Lahti R A, Roberts R C and Tamminga C A (1995) D2 family receptor distribution in human postmortem tissue’ An autoradiographic study Neuroreport 8, 2505–2512
Oke A, Keller R, Mefford I., and Adams R. (1978) Laterahsation of norepinephrine in human thalamus Science 200, 1411–1413
Owen F, Cross A J., Poulter M and Waddmgton J L (1979) Change in the haracteristics of 3H-spiperone binding to rat striatal membranes after acute hlorpromazine administration effects of buffer washing of membranes Life ci 25, 385–390
Palacios J M, Young W S, and Kuhar M J. (1980) GABA and benzodiazepine eceptors in rat and human brain’ autoradiographic localisation by a novel echnique, in Enzymes and Neurotransmitters in Mental Disease (Usdin E., ourkes T L, and Youdim M B H, eds), Wiley, London, pp 573–583
Palkovits M (1986) Microdissection of individual brain nuclei and areas, in euromethods 1, General Neurochemical Techniques (Boulton A A and Baker G. B., eds), Humana Press, New Jersey, pp 1–17
Perrett C W, Whatley S A, Ferner I N and Marchbanks R M (1992) Changes n relative levels of specific brain mRNA species associated with schizophrenia and depression Mol Brain Res 12, 163–171.
Perry E K, Perry R H, and Tomlinson B E (1982) The influence of agonal tatus on some neurochemical activities of postmortem human brain tissue Neurosci Lett 29, 303–307
Perry E K and Perry R H. (1983) Human brain neurochemistry-some postmortem problems Life Set 33, 1733–1743
Reynolds G. P, Riederer P, Jellmger K, and Gabriel E. (1981a) Dopamine eceptors and schizophrenia’ the neuroleptic drug problem Neuropharmacology 20, 1319–1320.
Reynolds G P, Riederer, P, Jellmger, K, and Gabriel, E. (1981b) Dopamine eceptors and schizophrenia’ the influence of neuroleptic drug treatment and isease symptoms, in Biological Psychiatry (Perris, C, Struwe, G, and Jansson, B, eds), Elsevier, Amsterdam, pp 718,719
Reynolds G P. Cowey L., Rossor M N, and Iversen L L. (1982) Thioridazine is ot specific for limbic dopamine receptors Lancet ii, 499,500
Reynolds G P. (1989) Beyond the dopamine hypothesis. The neurochemical athology of schizophrenia Br J Psych 55, 305–316
Reynolds G P (1996) Muscanninc Ml receptors in schizophrenia Mol Psych 1, 364–366
Reynolds G P and Pearson S J (1990) Brain GABA levels in asymptomatic untington’s disease. New Eng J Med 323, 682.
Riederer P, Kruzik P., Kienzl E, Kleinberger G., Jellmger K., and Wesemann W(1981) Central aminergic function and its disturbance by hepatic disease, in Transmitter Biochemistry of Human Brain Tissue (Riederer P and Usdin E, eds.), Macmillan, London, pp 143–182.
Riederer P, Gsell W, Calza L, Franzek E., Jungkunz G., Jellmger K, Reynolds G, Crow T, Cruz Sanchez F F and Beckman H. H. (1995) Consensus on minimal criteria of clinical and neuropathological diagnosis of schizophrenia and ffective-disorders for postmortem research-report from the european dementia and schizophrenia network J Neural Transm 102, 255–264
Rossor M. N, Iversen L L, Johnson A J, Mountjoy C Q., and Roth M (1981a) holinergic deficit in frontal cerebral cortex is age dependent Lancet ii, 1422
Rossor M N, Svendsen C, Hunt S. P, Mountjoy C Q, Roth M, and Iversen L (1981b) The substantia innominata in Alzheimer’s disease’ a histochemi-cal and biochemical study of cholinergic marker enzymes Neurosci Lett 28, 17–222.
Sardar M A, Czudek C, and Reynolds G.P. (1996) Dopamine deficits in the rain the neurochemical basis of parkinsonian symptoms in AIDS Neuroreport 7, 910–912
Shi S-R, Key M E and Kalra K L (1991) Antigen retrieval in formalin-fixed, araffin-embedded tissues An enhancement method for lmmunohistochemi-cal staining based on microwave oven heating of tissue sections J Histochem ytochem 39, 741–748
Smith J A, Mee T J. X, Padwick D. J., and Spokes E G. (1981) Human postmortem pineal enzyme activity Clin Endocrinol 14, 79–81.
Spokes E. G. S. and Koch D. J. (1978) Postmortem stability of dopamine, lutamate decarboxylase and choline acetyltransferase in the mouse brain under conditions simulating the handling of human autopsy material J Neurochem 31, 381–383
Spokes E G S (1979) An analysis of factors influencing measurements of dopamine, noradrenaline, glutamate decarboxylase and choline acetylase in human ostmortem brain tissue Brain 102, 333–346
Steelman V M (1994) Creutzfeld-Jakob disease Recommendations for infection control Am J Infec Control 22, 312–318
Swaab D F (1982) Cytochemical methods in neuroanatomy (Chan-Palay V, alay S L., eds.), A. R Liss, New York, pp. 423–440
Uylings H B M and Delalle I (1997) Morphology of neuropeptide-Y-immu-noreactive neurons and fibres in humanprefrontal cortex during prenatal nd postnatal development J Comp Neurol 379, 523–540
Volkow N D, Fowler J. S, Wang G J, Logan J, Schyler D, MacGregor R, Itzemann R. and Wolf A P (1994) Decreased dopamine transporters with ge m healthy human subjects. Ann Neurol 36, 237–239.
Wang G J, Volkow N D, Fowler J S, Logan J, Gur R and Netusil N (1996) Age associated decrements in dopamine D2 receptors in thalamus and in emporal insula of human subjects Life Set 59, PL31–PL35.
Weiser M, Riederer P. and Kleinberger G (1978) Human cerebral free amino cids in hepatic coma J Neural Transm Suppl14, 99–102
Whatley S A, Hall C, Davison A N, and Lim L (1984) Alterations in the relative amounts of specific mRNA species in the developing human brain in own’s syndrome. Biochem J 220, 179–187
Wilcock G K, Hope R A, Brooks D N, Lantos P L, Oppenheimer C, Reynolds P., Rossor M N. and Davies M. B. (1989) Reccomended mimmun data to e collected in research studies on Alzheimer’s disease J Neurol Neurosurg sychiat 52, 693–700
Winblad B, Adolfsson R, Carlsson A, and Gottfries C G (1982) Biogenic amines in brains of patients with Alzheimer’s disease, in Alzheimer’s Disease A Report of Progress (Corkin S et al, eds), Raven Press, New York, pp. 2933
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1999 Humana Press Inc
About this protocol
Cite this protocol
Reynolds, G.P., Beasley, C.L. (1999). Neurochemistry of Human Postmortem Brain. In: Cell Neurobiology Techniques. Neuromethods, vol 33. Humana Press. https://doi.org/10.1385/0-89603-510-7:319
Download citation
DOI: https://doi.org/10.1385/0-89603-510-7:319
Publisher Name: Humana Press
Print ISBN: 978-0-89603-510-2
Online ISBN: 978-1-59259-638-6
eBook Packages: Springer Protocols